Patents by Inventor Andrew Mark Scott

Andrew Mark Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EphA3 Antibodies for the Treatment of Solid Tumors
    Publication number: 20080286272
    Abstract: The invention provides methods and compositions comprising anti-EphA3 antibodies for the treatment of solid tumors.
    Type: Application
    Filed: March 10, 2008
    Publication date: November 20, 2008
    Applicants: KaloBios Pharmaceuticals, Inc., Ludwig Institute for Cancer Research, Monash University
    Inventors: Martin Lackmann, Andrew Mark Scott, Christopher R. Bebbington, Geoffrey T. Yarranton, Carmelina Murone, Catherine To
  • Anti-Lewis Y Anti-Idiotypic Antibodies and Uses Thereof
    Publication number: 20080268459
    Abstract: This invention provides anti-idiotype antibodies specific for Anti-Lewis Y monoclonal antibodies. The present invention also directed against an ELISA screening method of mAbs produced by hybridoma clones for specific binding to the variable regions of hu3S193 and the ability of the anti-idiotypic mAB to inhibit hu3S193 binding to Lewis Y antigen. Additionally, the present invention provides a hybridoma capable of producing an anti-idiotype antibody specific for anti-Lewis Y monoclonal antibody. A further aspect of the invention is to provide a hybridoma, which is specific for anti-Lewis Y monoclonal antibody selected from the group consisting of LMH-1, LMH-2, LMH-3, or LMH-4. The present invention is also directed against a method to detect HAMA, HACA and HAHA responses using the antibody of the invention.
    Type: Application
    Filed: August 10, 2004
    Publication date: October 30, 2008
    Inventors: Zhanqi Liu, Andrew Mark Scott, Fiona E. Smyth